Skip to main content
. 2023 Jun 20;13(12):2037. doi: 10.3390/ani13122037

Table 1.

Information (synthesis, manufacturer’s recommendations) about the commercial products that were used in this study.

Product Manufacturer Synthesis M.r. Dose 1
SPECTRON® HIPRA, Girona, Spain Enrofloxacin (100 mg/mL) 10 mg/kg BW
ProPhorce™ SA
Exclusive
Perstorp Holding AB, Malmö, Sweden Formic acid (50–60%), Sodium formate (20–30%), L-(+)-lactic acid (5–10%), Cinnamaldehyde (1–5%) 0.2% v/v
Premium acid Kanters, Lieshout, The Netherlands Formic acid (29%), propionic acid (7.5%), lactic acid (9.2%), acetic acid (2.5%), sorbic acid (0.2%), oligofructose syrup (1%), copper sulphate pentahydrate (0.5%), sodium chloride (0.1%), zinc chelate of glycine hydrated (0.1%) 0.2% v/v
Salgard® Liquid Anpario plc, Nottinghamshire, UK Ammonium formate (20%), propionic acid (5.2%), ammonium propionate (1%) and carrier 0.2% v/v

1 M.r. dose: Maximum recommended dosage by the manufacturer (when animals are present). According to the instructions, in some products the dose may be increased, whereas the evaluation of the optimal farm-specific dose is highly encouraged. For the products for which data were available, we included the percentage of the concentrations of individual compounds. It is important to note that all the products may contain additional proprietary ingredients used for stabilization and enhancing effectiveness.